Company: DERM
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041214
Chunk: 11

Company: Journey Medical Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 11
---
 by proxy, and entitled to vote on the subject matter is required to approve the ratification of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025. Abstentions will have the same effect as a vote “AGAINST” this proposal. Because this proposal is considered a routine matter under NYSE rules, where brokers have discretionary authority to vote in the absence of instructions, we do not expect any broker non-votes on this proposal. Q: What vote is required to approve the Fourth Amended and Restated Certificate of Incorporation providing for, among other things, officer exculpation in Proposal 3? A: The affirmative vote of the holders of a majority of the outstanding shares of our common stock and Class A common stock, voting together as a slinge class, is required to approve the Fourth Amended and 4 TABLE OF CONTENTS Restated Certificate of Incorporation providing for, among other things, officer exculpation. Abstentions and broker non-votes have the same effect as a vote “against” this proposal. Q: What percentage of our outstanding common stock do our directors, executive officers, and affiliated 5% beneficial owners own? A: As of April 14, 2025, our directors, executive officers, and affiliates who beneficially own 5% or more of our outstanding common stock collectively owned, or had the right to acquire, approximately 56.49% of our outstanding common stock. See the discussion under the heading “ Stock Ownership of Our Directors, Executive Officers, and 5% Beneficial Owners ” on page 24for more details. Q: Who was our independent public accountant for the year ended December 31, 2024? Will they be represented at the Annual Meeting? A: KPMG LLP is the independent registered public accounting firm that audited our financial statements for the year ended December 31, 2024. We expect a representative of KPMG LLP to be present virtually at the Annual Meeting. The representative will have an opportunity to make a statement and will be available to answer your questions. Q: How can I obtain a copy of our Annual Report on Form 10-K? A: We have filed our Annual Report on Form 10-K for the year ended December 31, 2024, with the SEC. The Annual Report on Form 10-K for the year ended December 31, 2024 is also available on the website referred to in the Internet Notice,